Arrowhead Pharmaceuticals (ARWR) Non-Current Debt (2011 - 2026)
Arrowhead Pharmaceuticals' Non-Current Debt was $181.4 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 9.5% from $200.33 million a year earlier but up 13.6% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Non-Current Debt (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Non-Current Debt at Arrowhead Pharmaceuticals came in at $214.88 million, down 45.3% from FY2024.
- In earlier fiscal years, Non-Current Debt was $393.18 million in FY2024.
- Quarterly Non-Current Debt has moved between $159.64 million (fiscal Q2 2026) and $407.79 million (fiscal Q1 2025) over five years.
- Compared with a year earlier, Non-Current Debt has declined for four straight quarters, with an average decline of 34.6% over the last four quarters.
- Per Business Quant data, ARWR's Non-Current Debt in the three fiscal quarters before Q3 2026 was $159.64 million (Q2 2026), $163.11 million (Q1 2026) and $214.88 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.62 Bn | 1,103.20 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 616.94 Bn | 535.47 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 501.32 Bn | 474.43 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.44 Bn | 321.82 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.20 Bn | 262.19 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.78 Bn | 235.47 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.88 Bn | 165.07 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Arrowhead Pharmaceuticals | 8.59 Bn | 3.37 Bn | - | 322.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 322.77 Mn |
| Mar 31, 2026 | 159.64 Mn |
| Dec 31, 2025 | 163.11 Mn |
| Sep 30, 2025 | 214.88 Mn |
| Jun 30, 2025 | 200.33 Mn |
| Mar 31, 2025 | 208.93 Mn |
| Dec 31, 2024 | 407.79 Mn |
| Sep 30, 2024 | 393.18 Mn |
| Sep 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Mar 31, 2019 | 2.70 Mn |
| Dec 31, 2018 | 2.30 Mn |
| Sep 30, 2018 | 2.10 Mn |
| Jun 30, 2018 | 2.16 Mn |
| Mar 31, 2018 | 2.22 Mn |
| Dec 31, 2017 | 2.27 Mn |
| Sep 30, 2017 | 2.33 Mn |
| Jun 30, 2017 | 2.38 Mn |
| Mar 31, 2017 | 2.43 Mn |
| Dec 31, 2016 | 2.48 Mn |
API Access
Arrowhead Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();